Nucleome Therapeutics

Developer of nucleome therapeutics for multiple diseases

placeOxford, England, United Kingdom calendar_todayFounded 2019 groups14 employees language nucleome.com

Registered entities

Social engagement

Social engagement: 7.9K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

9 investors on record; lead investors include M Ventures.

Investor typeCountShare
Venture capital444%
Accelerator & incubator111%
Other / undisclosed444%

Hiring activity

Hires occasionally

1 role tracked across 1 of the last 12 months

Based on job postings tracked across public sources.

Recent activity

16 Jun 2026
Event
BIO International Convention 2026
28 May 2026
Event
EULAR2026
21 May 2026
Event
Antibody Engineering & Therapeutics 2026
Coming soon